About Fapon

Driving human civilization forward

Overview
Culture
Strategy
History
Globalization

Overview

Fapon is a global leading life sciences company dedicated to providing integrated solutions and services for diagnostics, biopharma, biotherapy, and intelligent diagnosis and treatment. Integrating a one-stop solution on raw materials, reagents and innovative open instrument platforms, Fapon has grown into a leading in vitro diagnostics supplier. Fapon boasts advanced innovations in therapeutics technologies and AI algorithm platforms with data insights that contribute to a better and healthier world.

1200 +

patent applications worldwide
1400 +

industrial-grade raw materials
2500

global business partners

Culture

Driving human civilization forward

As a biotech company, we are on a mission to improve healthcare for all, to let everyone live a healthier and better life, and to protect our planet as well. By doing this, we are helping to create a better future and advance civilization.

Core values

Think bigger
Start tomorrow today
Go bold
Continue evolving
Keep it simple

Think bigger / Start tomorrow today

Go bold / Continue evolving / Keep it simple

Strategy

Three-wave strategy

Six-dimensional approach

Fapon is built on pioneering technologies and products. We rely on innovation and talent to improve human health.

Leading in technologies and products

Developing an R&D-driven organization that offers premium patented products and services

Driven by talent and innovation

Attracting and retaining talent worldwide, seizing opportunities in the industry and the capital market

Building a solid platform-based organization and an ecosystem that benefits everyone in the industry

Leading in technologies and products

Developing an R&D-driven organization that offers premium patented products and services

Driven by talent and innovation

Attracting and retaining talent worldwide, seizing opportunities in the industry and the capital market

Leading in technologies and products

Developing an R&D-driven organization that offers premium patented products and services

History

2001

Fapon Biotech was founded.
2009

Fapon Biotech became the market leader in IVD raw materials in China；

We started building a pipeline of molecular diagnostics products.
2015

We entered the field of biopharma, focusing on cancers and autoimmune diseases.
2017

We pioneered total solutions on instruments and reagents for the ecosystem model.
2019

We embraced AI-enabled healthcare, and incubated innovative projects using biotechnologies and AI-enabled data insights.
2023

We started developing innovative diagnostic model and circular RNA technology platform.

2001

Fapon Biotech was founded.

2009

Fapon Biotech became the market leader in IVD raw materials in China；

We started building a pipeline of molecular diagnostics products.

2015

We entered the field of biopharma, focusing on cancers and autoimmune diseases.

2017

We pioneered total solutions on instruments and reagents for the ecosystem model.

2019

We embraced AI-enabled healthcare, and incubated innovative projects using biotechnologies and AI-enabled data insights.

2023

We started developing innovative diagnostic model and circular RNA technology platform.

Globalization

To fulfill our mission to build a better, healthier world, we have taken a people-oriented and technology-empowering approach to global business cooperation for the past two decades. With our pioneering and customized products, services and technologies, we participate in local welfare programs, and help our business partners around the world develop their local healthcare industry.

68

countries and regions
5

R&D Centers

Dongguan R&D Center (HQ)

Dongguan R&D Center (HQ)

With comprehensive platforms of diagnostics and innovative biotechnology in multiple R&D facilities, we focus on IVD raw material solutions, IVD ecosystem, and biopharma & biotherapy.

Shenzhen R&D Center

Shenzhen R&D Center

Specializing in CLIA instruments and sequencers, we invite partners in the industry to join the open ecosystem, and use the diagnostics platforms of high quality to improve their reagent performance and operations efficiency.

Shanghai R&D Center

Shanghai R&D Center

We research on drug development including innovative targets, screening for drug candidates, prediction of drug safety and innovative antibody therapeutics, using molecular simulation, AI-enabled drug design and innovative biopharma technologies.

San Francisco R&D Center

San Francisco R&D Center

The San Francisco R&D Center specializes in sequencing and AI algorithms. In sequencing, we offer cost-effective NGS solutions for upstream, mid-stream and downstream partners, and deliver accessible sequencing services for all by means of flexible chip design, innovative fluidics solutions, efficient and sensitive biochemistry reagents. In AI algorithms, by combining multi-omics data and AI technologies, we improve the efficiency and accuracy of biomarker discovery, and thus accelerate the translation of innovative diagnostics.

Boston R&D Center

Boston R&D Center

The Boston R&D Center specializes in molecular diagnostic enzymes and mRNA. In molecular diagnostic enzymes, we aim to modify existing enzymes and discover new enzymes. Collaborating with headquarters, we strive for breakthroughs in precision diagnosis and mRNA technologies. At our mRNA gene therapy incubation center, we leverage the distinct advantage of mRNA in not integrating into the human DNA, minimizing the risk associated with genetic modification. Through continuous technological refinement, we are committed to developing mRNA-based drugs and vaccines that are more effective, safe, and stable for infectious diseases and tumor immunotherapy.

Scan WeChat QR Code